|
Name |
(1S,2S)-2-[(2R,4Z,6E,8S,9R,13R,15R,16R)-7-cyano-8,16-dihydroxy-9,11,13,15-tetramethyl-18-oxo-1-oxacyclooctadeca-4,6-dien-2-yl]cyclopentane-1-carboxylic acid
|
| Molecular Formula | C28H43NO6 | |
| IUPAC Name* |
(1S,2S)-2-[(2R,4Z,6E,8S,9R,13R,15R,16R)-7-cyano-8,16-dihydroxy-9,11,13,15-tetramethyl-18-oxo-1-oxacyclooctadeca-4,6-dien-2-yl]cyclopentane-1-carboxylic acid
|
|
| SMILES |
C[C@H]1C[C@H]([C@@H](CC(=O)O[C@H](C/C=C\C=C(\[C@H]([C@@H](CC(C1)C)C)O)/C#N)[C@H]2CCC[C@@H]2C(=O)O)O)C
|
|
| InChI |
InChI=1S/C28H43NO6/c1-17-12-18(2)14-20(4)27(32)21(16-29)8-5-6-11-25(22-9-7-10-23(22)28(33)34)35-26(31)15-24(30)19(3)13-17/h5-6,8,17-20,22-25,27,30,32H,7,9-15H2,1-4H3,(H,33,34)/b6-5-,21-8+/t17-,18?,19-,20-,22+,23+,24-,25-,27+/m1/s1
|
|
| InChIKey |
OJCKRNPLOZHAOU-MJQQLCDASA-N
|
|
| Synonyms |
Borrelidin; 7184-60-3
|
|
| CAS | 7184-60-3 | |
| PubChem CID | 133655849 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 489.6 | ALogp: | 5.6 |
| HBD: | 3 | HBA: | 7 |
| Rotatable Bonds: | 2 | Lipinski's rule of five: | Rejected |
| Polar Surface Area: | 128.0 | Aromatic Rings: | 2 |
| Heavy Atoms: | 35 | QED Weighted: | 0.461 |
| Caco-2 Permeability: | -5.346 | MDCK Permeability: | 0.00001420 |
| Pgp-inhibitor: | 0.023 | Pgp-substrate: | 0.384 |
| Human Intestinal Absorption (HIA): | 0.206 | 20% Bioavailability (F20%): | 0.01 |
| 30% Bioavailability (F30%): | 0.94 |
| Blood-Brain-Barrier Penetration (BBB): | 0.029 | Plasma Protein Binding (PPB): | 98.76% |
| Volume Distribution (VD): | 0.714 | Fu: | 2.59% |
| CYP1A2-inhibitor: | 0.035 | CYP1A2-substrate: | 0.078 |
| CYP2C19-inhibitor: | 0.045 | CYP2C19-substrate: | 0.64 |
| CYP2C9-inhibitor: | 0.523 | CYP2C9-substrate: | 0.706 |
| CYP2D6-inhibitor: | 0.002 | CYP2D6-substrate: | 0.038 |
| CYP3A4-inhibitor: | 0.441 | CYP3A4-substrate: | 0.202 |
| Clearance (CL): | 9.015 | Half-life (T1/2): | 0.876 |
| hERG Blockers: | 0.027 | Human Hepatotoxicity (H-HT): | 0.969 |
| Drug-inuced Liver Injury (DILI): | 0.97 | AMES Toxicity: | 0.006 |
| Rat Oral Acute Toxicity: | 0.266 | Maximum Recommended Daily Dose: | 0.943 |
| Skin Sensitization: | 0.634 | Carcinogencity: | 0.202 |
| Eye Corrosion: | 0.005 | Eye Irritation: | 0.049 |
| Respiratory Toxicity: | 0.768 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC002735 | ![]() |
0.283 | D08XAC | ![]() |
0.253 | ||
| ENC001935 | ![]() |
0.262 | D06WTZ | ![]() |
0.250 | ||
| ENC005766 | ![]() |
0.252 | D02DWM | ![]() |
0.248 | ||
| ENC002580 | ![]() |
0.250 | D0H0ND | ![]() |
0.246 | ||
| ENC001414 | ![]() |
0.250 | D04SFH | ![]() |
0.244 | ||
| ENC003767 | ![]() |
0.248 | D0F5OR | ![]() |
0.244 | ||
| ENC002054 | ![]() |
0.248 | D02FEM | ![]() |
0.243 | ||
| ENC003784 | ![]() |
0.248 | D0L6QI | ![]() |
0.235 | ||
| ENC005098 | ![]() |
0.248 | D0OR2L | ![]() |
0.234 | ||
| ENC002215 | ![]() |
0.248 | D06OMK | ![]() |
0.232 | ||